Works matching IS 09650407 AND DT 2024 AND VI 32 AND IP 12

Results: 10

Liver-directed therapies for fibrolamellar carcinoma: A single-center experience.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1831, doi. 10.32604/or.2024.052985
By:
- SON, SAM;
- BRAHMBHATT, AKSHAAR;
- ZHAO, KEN;
- MARINELLI, BRETT;
- HARDING, JAMES;
- JARNAGIN, WILLIAM;
- ABOU-ALFA, GHASSAN K.;
- YARMOHAMMADI, HOOMAN
Publication type:
Article
The superiority of PMFs on reversing drug resistance of colon cancer and the effect on aerobic glycolysis-ROS-autophagy signaling axis.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1891, doi. 10.32604/or.2024.048778
By:
- YIN, YUQIN;
- WU, YU;
- HUANG, HONGLIANG;
- DUAN, YINGYING;
- YUAN, ZHONGWEN;
- CAO, LIHUI;
- YING, JINJIN;
- ZHOU, YONGHENG;
- FENG, SENLING
Publication type:
Article
Identification of M2 macrophage-related genes for establishing a prognostic model in pancreatic cancer: FCGR3A as key gene.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1851, doi. 10.32604/or.2024.055286
By:
- WANG, ZHEN;
- FU, JUN;
- ZHU, SAISAI;
- TANG, HAODONG;
- SHI, KUI;
- YANG, JIHUA;
- WANG, MENG;
- WU, MENGGE;
- QI, DUNFENG
Publication type:
Article
CES1 is associated with cisplatin resistance and poor prognosis of head and neck squamous cell carcinoma.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1935, doi. 10.32604/or.2024.052244
By:
- JIANG, CHUAN;
- LIU, CHUNLEI;
- YAO, XI;
- SU, JINGYA;
- LU, WEI;
- WEI, ZHENGBO;
- XIE, YING
Publication type:
Article
hsa-miR-181a-5p inhibits glioblastoma development via the MAPK pathway: in-silico and in-vitro study.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1949, doi. 10.32604/or.2024.051569
By:
- SHADBAD, MAHDI ABDOLI;
- BARADARAN, BEHZAD
Publication type:
Article
Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1837, doi. 10.32604/or.2024.056565
By:
- ZHENG, WEITAO;
- JIANG, DONG;
- CHEN, SONGEN;
- WU, MEILING;
- YAN, BAOQI;
- ZHAI, JIAHUI;
- SHI, YUNQIANG;
- XIE, BIN;
- XIE, XINGWANG;
- HU, KANGHONG;
- MA, WENXUE
Publication type:
Article
A comprehensive and systematic analysis of Dihydrolipoamide S-acetyltransferase (DLAT) as a novel prognostic biomarker in pan-cancer and glioma.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1903, doi. 10.32604/or.2024.048138
By:
- ZHOU, HUI;
- YU, ZHENGYU;
- XU, JING;
- WANG, ZHONGWANG;
- TAO, YALI;
- WANG, JINJIN;
- YANG, PEIPEI;
- YANG, JINRONG;
- NIU, TING
Publication type:
Article
Using Multi-Omics Analysis to Explore Diagnostic Tool and Optimize Drug Therapy Selection for Patients with Glioma Based on Cross-Talk Gene Signature.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1921, doi. 10.32604/or.2024.046191
By:
- YANG, YUSHI;
- HU, CHUJIAO;
- LEI, SHAN;
- BAO, XIN;
- ZENG, ZHIRUI;
- CAO, WENPENG
Publication type:
Article
LncRNA AFAP1-AS1 exhibits oncogenic characteristics and promotes gemcitabine-resistance of cervical cancer cells through miR-7-5p/EGFR axis.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1867, doi. 10.32604/or.2024.044547
By:
- WANG, CHAOQUN;
- ZHANG, TING;
- ZHANG, CHAOHE
Publication type:
Article
Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer.
Published in:
Oncology Research, 2024, v. 32, n. 12, p. 1881, doi. 10.32604/or.2024.048007
By:
- YIN, YUAN;
- WANG, ZHENGYIN;
- HU, YUJIE;
- WANG, JIA;
- WANG, YI;
- LU, QUN
Publication type:
Article